LEXX

2.86

4.35% -0.13

Dopo l'orario di chiusura: 2.90 0.04 +1.40%

Lexaria Bioscience Corp (LEXX)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$2.99

Aprire:

$3.19

Volume 24 ore:

123.31K

Relative Volume:

1.43

Capitalizzazione di mercato:

$6.02M

Reddito:

$368.00K

Utile/perdita netta:

$-9.54M

Rapporto P/E:

-5.9733

EPS:

-0.4788

Flusso di cassa netto:

$-9.47M

1 W Prestazione:

-13.86%

1M Prestazione:

-7.59%

6M Prestazione:

-80.64%

1 anno Prestazione:

-76.88%

Intervallo 1D:

$2.81

$3.24

Intervallo di 1 settimana:

$2.43

$3.6235

Portata 52W:

$2.43

$21.60

Lexaria Bioscience Corp Stock (LEXX) Company Profile

Nome

Lexaria Bioscience Corp

Settore

Healthcare (1052)

Industria

Biotechnology (594)

Telefono

250-765-6424

Indirizzo

100 - 740 MCCURDY ROAD, KELOWNA

Dipendente

Cinguettio

Prossima data di guadagno

2026-11-25

Ultimi documenti SEC

LEXX's Discussions on Twitter

Compare LEXX vs VRTX, MRNA, REGN, ARGX, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
LEXX Lexaria Bioscience Corp	2.86	6.02M	368.00K	-9.54M	-9.47M	-0.4788
VRTX Vertex Pharmaceuticals Inc	499.74	126.66B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	218.01	87.04B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	790.74	81.41B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	819.14	51.51B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	369.06	41.75B	5.76B	514.49M	1.10B	4.4813

Lexaria Bioscience Corp Borsa (LEXX) Ultime notizie

Sep 30, 2026

Immix Biopharma Announces Closing of $125 Million Underwritten Offering of Common Stock - Investing News Network

Sep 30, 2026

Sep 29, 2026

Immix Biopharma Announces Pricing of $125 Million Underwritten Offering of Common Stock - Investing News Network

Sep 29, 2026

Sep 09, 2026

Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds - Investing News Network

Sep 09, 2026

Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds - ACCESS Newswire

Sep 09, 2026

Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds - Weatherford Democrat

Sep 09, 2026

Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds - Yahoo! Finance Canada

Sep 09, 2026

Lexaria Raises $5.9M in Warrant Exercise Transaction - Minichart

Sep 09, 2026

Lexaria Bioscience Raises $5.9 Million Via Warrant Exercise; Issues New Warrants, Engages Wainwright - TradingView

Sep 09, 2026

$5.9 million raised as Lexaria issues new rights to buy shares - Stock Titan

Sep 09, 2026

Sep 08, 2026

Primer: Lexaria Bioscience (LEXX US)Sep 2026 - Smartkarma

Sep 08, 2026

Lexaria Raises $5.9 Million Via Warrant Exercise and Issues New Warrants - TipRanks

Sep 08, 2026

Lexaria raises $5.9M by exercising warrants at reduced price to fund 2027 operations and R&D. - Pluang

Sep 08, 2026

Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds - investingnews.com

Sep 08, 2026

Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds - corsicanadailysun.com

Sep 08, 2026

Lexaria Announces Exercise of Warrants For Approximately $5.9 Million in Gross Proceeds - TradingView

Sep 08, 2026

A potential $5.9 million plus a $2.6 million rebate may fund Lexaria's 2027 research - Stock Titan

Sep 08, 2026

LEXX: Introducing DehydraTECH 3.0 - Yahoo Finance

Sep 08, 2026

Sep 04, 2026

Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Investing News Network

Sep 04, 2026

Lexaria to present at H.C. Wainwright Global Investment Conference in September 2026 - Pluang

Sep 04, 2026

Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference - ncnewsonline.com

Sep 04, 2026

A drug-delivery company holds 66 granted patents. Lexaria plans a New York presentation. - Stock Titan

Sep 04, 2026